Thomas A Fitzgerald insider trades
Open-market stock purchases and sales by Thomas A Fitzgerald, Chief Financial Officer at Transcode Therapeutics, Inc, from SEC Form 4 filings since Feb 1, 2022.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +136%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | RNAZ Transcode Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- RNAZ Transcode Therapeutics, Inc: 2 buys, last Sep 9, 2026
Get free alerts when Thomas A Fitzgerald files a new trade →